Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Author Archives for admin

    Chondrosarcoma Foundation’s Third Anniversary Shows Appreciation to It’s Donors, Supporters and Partners

    May 12, 2023 6:01 pm Published by Comments Off on Chondrosarcoma Foundation’s Third Anniversary Shows Appreciation to It’s Donors, Supporters and Partners

    During the past three years many CS Patients, caregivers, family members and friends have supported the Foundation through their donations and fund-raising activities. We received donations from family members in honor of their lost loved ones to this beast. We have had others like Julie Mathews that supported 5K walk / runs. Lifecycle holdings in [...]


    Chondrosarcoma Foundation Enters Fourth Year, Marks Progress

    May 11, 2023 12:27 am Published by Comments Off on Chondrosarcoma Foundation Enters Fourth Year, Marks Progress

    BOWIE, Maryland, May 12—The Chondrosarcoma (CS) Foundation will commemorate its third anniversary by continuing to educate the public about this rare bone cancer, advocate for patients fighting the disease and conduct a global natural history study. On May 14, 2020, the CS Foundation was incorporated, six months after Shayna Elise Kramer lost her battle with [...]


    Update on Chondrosarcoma Patient Registry

    April 28, 2023 6:30 pm Published by Comments Off on Update on Chondrosarcoma Patient Registry

    The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, 2023. The Chondrosarcoma Patient Registry is a platform for patients around the world to strengthen their voices and collectively share information about this rare bone cancer. This global resource will provide data for researchers to use to advance drug development [...]


    Biomarkers of chondrosarcoma

    April 22, 2023 2:25 am Published by Comments Off on Biomarkers of chondrosarcoma

    Journal of Clinical Pathology J Clin Pathol. 2018 Jul; 71(7): 579–583. Published online 2018 Mar 28. doi: 10.1136/jclinpath-2018-205071 PMCID: PMC6204964 PMID: 29593061 Biomarkers of chondrosarcoma Wonju Jeong1 and Ha-Jeong Kim2,3 Abstract Clinical outcome prediction is major concern to patients with cancer. Various molecular markers in various carcinomas have been identified in the past few decades. [...]


    Update on INBRX Clinical Trials from Inhibrx

    April 11, 2023 9:01 pm Published by Comments Off on Update on INBRX Clinical Trials from Inhibrx

    The INBRX 109 Clinical Trials will shortly resume recruiting patients for their Phase 2 Clinical Trial treating patients with Conventional Chondrosarcoma with recurrence or metastasis. Listed below is a response from Inhibrx: We have just released our newest amendment to the protocol for both the Phase 2 and Phase I INBRX-109. These protocols both now [...]


    Chondrosarcoma Patient Registry at one month

    April 7, 2023 8:10 pm Published by Comments Off on Chondrosarcoma Patient Registry at one month

    The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, a little over one month ago. The registry currently has 60 participants. We want to encourage everyone in the community to participate. The patient information that the registry collects will help give direction to scientists on areas in which to [...]


    Chondrosarcoma Resistance to Radiation Therapy: Origins and,Potential Therapeutic Solutions

    March 29, 2023 1:12 am Published by Comments Off on Chondrosarcoma Resistance to Radiation Therapy: Origins and,Potential Therapeutic Solutions

    Antoine Gilbert 1, Mihaela Tudor 2,3, Juliette Montanari 1, Kevin Commenchail 1 , Diana Iulia Savu 2 ,Paul Lesueur 4,5,6 and François Chevalier 1,* Simple Summary: This review article aims in describing the origins of chondrosarcoma radiation-resistance and proposes several potential solutions in order to improve the treatment, in regard with tumor grade and characteristics. [...]


    The First Twerk Walking Out Of The Hospital After Kicking Cancer’s Ass Has To Be The Sweetest

    March 23, 2023 12:44 am Published by Comments Off on The First Twerk Walking Out Of The Hospital After Kicking Cancer’s Ass Has To Be The Sweetest

    Some of you may not know who Amber Sarcone is. In Philly, she’s a part of the royal family. Her family runs Sarcone’s Bakery, makers of some of the most delicious damn bread you’ll ever have the pleasure of shoving into your mouth. Her cousin is Danny, who owns Angelo’s Pizzeria–makers of the best cheesesteak [...]


    Revolutionary new bone cancer drug identified

    March 16, 2023 8:36 pm Published by Comments Off on Revolutionary new bone cancer drug identified

    A research team led by Dr Darrell Green, a trustee of the Bone Cancer Research Trust, have identified a new drug that works against all main forms of bone cancer. Researchers at the University of East Anglia discovered that the drug, called ‘CADD522’, works by blocking a gene associated with metastatic disease. Preliminary studies suggest [...]


    Recruitment Efforts Underway for the Chondrosarcoma Patient Registry

    March 15, 2023 6:22 pm Published by Comments Off on Recruitment Efforts Underway for the Chondrosarcoma Patient Registry

    The Chondrosarcoma Foundation in partnership with the National Organization for Rare Disorders (NORD®) has launched the Chondrosarcoma Patient Registry. The patient registry creates a platform for patients around the world to strengthen their voices and provide critical information about their experiences living with this rare bone cancer. This global resource will provide data for researchers [...]


    Skip to content